Pharma Conversations Podcast
by Pharma Conversations Podcast
Latest episode
Inspection Readiness Through Culture, Collaboration, and Risk…
Inspection Readiness Through Culture, Collaboration, and Risk…
About this podcast
Conversations with Leaders Shaping Pharma’s Future
Episodes
- Inspection Readiness Through Culture, Collaboration, and Risk - Patricia Grimes · 43 minIn this episode, Patricia Grimes of Orion GXP Consulting discusses what it means to be inspection-ready as an everyday practice, not to appear perfect, but to manage risk…
- Employee Number One: Building WuXi Biologics in Dundalk, Ireland - Brendan McGrath · 32 minIn this episode, Brendan McGrath shares his story of him being the first employee of WuXi Biologics in Ireland and how he helped turn an empty site into a 46,000 m² biologics…
- Bridging Europe’s Biotech ‘Valley of Death’: Inside Ireland’s ARC Hub for Therapeutics - Araz Raoof · 37 minExecutive Director of the ARC Hub* for Therapeutics, Araz Raoof, joins Pharma Conversations to unpack why Europe leads the world in scientific papers yet lags in new drug…
- Ireland’s Missing Pharma Engine: Why Indigenous SMEs Matter - Paul McCabe · 59 minIn this episode of Pharma Conversations, Paul McCabe, COO of APC/VLE unpacks the hidden world of Ireland’s indigenous biopharma SMEs, and why, despite a world-class multinational…
- Use Less, Make More: Sustainability and the Future of Pharma - Michael Kilkelly · 29 minSustainability in pharma isn’t a side project anymore – it’s fast becoming core operational excellence. In this episode of Pharma Conversations, we sit down with Michael Kilkelly…
- Seeing What Matters: Modern Visual Inspection in Pharma - John Shabushnig · 34 minIn this episode John Shabushnig, founder of Insight Pharma Consulting explains what visual inspection really means for injectable products, from manual methods to advanced…
- Sterilisation of Indirect Product Contact Parts - Maria Ginnelly · 52 minIn this episode of Pharma Conversations, Maria Ginnelly explains the impact of the EU GMP Annex 1 (section 5.5) on the sterilisation of indirect product-contact parts in sterile…
- Launching Pharma in Europe - Charley Maxwell · 38 minIn this episode, Charlie Maxwell of Orion GXP Consulting, breaks down what non‑EU pharma and biotech companies need to get right when launching in Europe, from choosing the right…
- AI in Pharma - Martin Lush · 53 minIn this episode, Martin Lush of Martin Lush Consulting, breaks down how pharma organizations can safely and effectively adopt AI without sacrificing GMP, quality, or critical…
- Quality Culture - Craig Jacobs · 47 minIn this episode Craig Jacobs, Quality Culture Momentum Specialist of Affirm8 Quality Consultancy, unpacks what “quality culture” truly means in life sciences organizations. He…
- Designing Tech Transfer for Reality - Joe Brady · 47 minIn this episode, tech transfer expert and lecturer Joe Brady explains why most projects are “already late on day one” and unpacks the real causes of delay across the product…
- Knowledge Management - Melanie Byrne Adams · 46 minIn this episode of Pharma Conversations, we sit down with Melanie Adams, Associate Director, Knowledge Management at MSD, to unpack what knowledge management really is and how it…
- Annex 1 in Practice: Contamination Control, Legacy Facilities & Global Lessons - Jim Polarine · 49 minIn this episode, Jim Polarine from STERIS breaks down how Annex 1 is reshaping contamination control strategy world wide covering CCS design, risk‑based decision making, residue…
- Disinfection Rotation - Laura Brennan · 32 minIn this episode of Pharma Conversations, Laura Brennan Director of Technical Consulting at Ecolab breaks down the science and regulation behind disinfectant rotation in pharma…
- Ireland’s Pharma Powerhouse: Investment, Innovation & Future Growth - Rory Mullen · 26 minIn this episode, Rory Mullen, Head of Biopharma and Food at IDA Ireland, discusses how Ireland has evolved into a leading hub for pharmaceutical and biopharmaceutical…
- Quality Risk Management - Kevin O'Donnell · 46 minIn this episode of Pharma Conversations Podcast, Kevin O’Donnell (HPRA) explains how QRM needs to move beyond tick‑box exercises to become truly knowledge‑driven and…
- Unannounced FDA Inspections - Patrick Nieuwenhuizen · 30 min · Season 1 Episode 3In this episode of Pharma Conversations, we’re joined by Patrick Nieuwenhuizen, a global leader in pharmaceutical quality, compliance, and sterility assurance with more than 30…
- 2026 Inspection Readiness and Lessons Learned - Kevin O'Donnell · 45 minIn this episode of Pharma Conversations, we’re joined by Kevin O’Donnell, Market Compliance Manager and Senior GMP Inspector at the HPRA, to discuss what good inspection…
- Pharma’s Biggest Industry Trends and Challenges - Matt Moran · 30 min · Season 1 Episode 1Matt Moran breaks down the challenges shaping the pharmaceutical industry from supply‑chain fragility and increasing regulatory complexity to the urgent need for sustainability…








